Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements Of Redeemable Preferred Stock and Stockholders' Equity (Unaudited)

v3.21.1
Consolidated Statements Of Redeemable Preferred Stock and Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Series E Convertible Preferred Stock
Series F Convertible Preferred Stock
Common Stock
Common Stock
Series F Convertible Preferred Stock
Additional Paid-in Capital
Additional Paid-in Capital
Series F Convertible Preferred Stock
Convertible Preferred Stock
Series F Convertible Preferred Stock
Accumulated Other Comprehensive Loss
Accumulated Deficit
Beginning balance at Dec. 31, 2019 $ 377     $ 31   $ 235,594     $ (701) $ (234,547)
Beginning balance at Dec. 31, 2019   $ 3,965                
Beginning balance, shares at Dec. 31, 2019   70,000                
Balance (in shares) at Dec. 31, 2019       31,439,000            
Settlement of liability awards 151         151        
Stock-based compensation 640         640        
Issuance of stock from RSUs, net, shares       98,000            
Net loss (6,006)                 (6,006)
Foreign currency translation adjustments (18)               (18)  
Ending balance at Mar. 31, 2020 (4,856)     $ 31   236,385     (719) (240,553)
Ending Balance at Mar. 31, 2020   $ 3,965                
Balance (in shares) at Mar. 31, 2020       31,537,000            
Ending balance, shares at Mar. 31, 2020   70,000                
Beginning balance at Dec. 31, 2020 10,028     $ 98   261,573     (385) (251,376)
Beginning balance at Dec. 31, 2020             $ 118    
Beginning balance, shares at Dec. 31, 2020 0   882         1,000    
Balance (in shares) at Dec. 31, 2020 97,709,000     97,709,000            
Conversion of convertible preferred stock         $ 2   $ 612 $ (614)    
Conversion of convertible preferred stock, shares         1,535,000     (1,000)    
Sale of common stock $ 13,292     $ 14   13,278        
Sale of common stock, shares     17,000 14,000,000            
Issuance of common stock for settlement of liability 510         510        
Issuance of common stock for settlement of liability, Shares       500,000            
Deemed Dividend on Convertible Preferred Stock (532)           $ (532) $ 532    
Stock-based compensation 1,695         1,695        
Exercise of common stock warrants 15,040     $ 35   15,005        
Exercise of common stock warrants, shares       35,669,000            
Net loss (6,901)                 (6,901)
Foreign currency translation adjustments (148)               (148)  
Ending balance at Mar. 31, 2021 33,516     $ 149   $ 292,141     $ (533) $ (258,277)
Ending Balance at Mar. 31, 2021             $ 36    
Balance (in shares) at Mar. 31, 2021 149,427,000     149,413,000            
Ending balance, shares at Mar. 31, 2021 0   268